Irbesartan in the Treatment of Hypertensive Patients With Metabolic Syndrome

Clinical trial NCT00110422 · COMPLETED

Trial details

NCT number: NCT00110422
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Metabolic Syndrome Hypertension

Start date: 2005-11-01
Primary completion: 2007-02-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.